GlobeNewswire by notified

Blue California Expands Natural Flavor and Fragrance Portfolio with Production of Clean, Natural, and Sustainable Nerolidol

Share

Rancho Santa Margarita, Calif., Dec. 15, 2021 (GLOBE NEWSWIRE) -- Blue California announced the expansion of its natural flavor and fragrance portfolio of captive ingredients by producing a clean, sustainable nerolidol.

Nerolidol is a rare sesquiterpene alcohol ubiquitous in nature and found in many flowers and plants, particularly in Seville orange flower, also known as Neroli, which gives the aroma chemical its name.

It is recognized for its floral, woody aroma and can also be described as a fresh scent, blending well with citrus, apple, or rose but light enough to complement any type of scent or flavor. Nerolidol is therefore ideal for use in many applications and known for its relaxing effects.

Many brands looking to make products at a large scale using nerolidol find it to be cost-prohibitive and, for that reason, it hasn't been widely used in modern-day product applications.

Yet, consumers seek clean-label fragrance products that are easy on the planet and fit into the clean and conscious fragrance and beauty movement. The Innova Beauty & Personal Care Survey 2020 notes that 51% of global consumers indicate that natural ingredients are very or extremely important to them when purchasing fragrances.

"Biotechnology is opening doors to sustainable ingredients that weren't previously possible," said Kathy Oglesby, head of flavors and fragrances at Blue California. "Our collaboration with innovation partner Conagen provides efficient and effective commercialization, leading us to deliver to our client-creators a full range of captive ingredients, trademarked Plantarôme,™ for use in our flavors and fragrances."

Nerolidol is first in a full range of natural ingredients in the 2022 pipeline of Blue California's Taste, Smell, and Beauty Division. Conagen develops one of the most high-yielding fermentation platforms for producing sesquiterpenes and lactones.

With its functional advantages in many industries due to its moderate polarity and optical activity, nerolidol is also a useful, sustainable fine chemical intermediate.

"Nerolidol is a foundational material with many uses in many markets. Plantarôme™ S is a sandalwood type material, and Plantarôme™ M, which is a natural musk, are both creating a lot of excitement in the marketplace," said Oglesby.

Until now, synthetic musk was primarily used in the fragrance industry because traditional musk sources were wild plants, too rare to be useful, or wild animals, like musk deer and civet cats, too endangered to be ethical. Conagen and Blue California have teamed together to develop a modern, one-of-a-kind, natural, domestic plant-derived musk that is safe, versatile, and biodegradable.

"The launch of nerolidol is symbolic of the collaboration between Blue California and Conagen as we advance in the markets we can serve," said Casey Lippmeier, Ph.D. vice president of innovation at Conagen. "Together, we are revolutionizing the flavor and fragrance ingredient industry with our disruptive capabilities for producing clean, sustainable solutions and product applications."

About Blue California

Blue California is an entrepreneurial, science-based solutions provider and manufacturer of clean, natural, and sustainable ingredients used in food, beverage, flavor, fragrance, dietary supplements, personal care, and cosmetic products. For more than 25 years, Blue California has built a strong reputation for creating value in these diverse natural products and nature-inspired industries. www.bluecal-ingredients.com

About Conagen

Conagen is a product-focused, synthetic biology R&D company with large-scale manufacturing affiliates. Our scientists and engineers use the latest synthetic biology tools to develop high-quality, sustainable, nature-based products by precision fermentation and enzymatic bioconversion. We focus on the bioproduction of high-value ingredients for food, nutrition, flavors and fragrances, pharmaceutical, and renewable materials industries. www.conagen.com

Attachments

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Correction to Company announcement – No. 23 / 202419.4.2024 22:20:51 CEST | Press release

Correction to Company announcement – No. 23 / 2024 Copenhagen, Denmark, April 19, 2024 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has a correction to company announcement No. 23 /2024, April 19, 2024 - regarding transactions in Zealand’s shares or related securities conducted by persons discharging managerial responsibilities and/or their closely associated persons it was reported that member of the management, Henriette Wennicke, was allocated a total of 8,008 restricted stock units with a total value of DKK 9,577,568.00. The correct number was a total of 8,008 restricted stock units with a total value of DKK 4,788,784.00. Please see the attached file(s). # # # About Zealand Pharma A/S Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10

Nokia Corporation: Repurchase of own shares on 19.04.202419.4.2024 21:30:00 CEST | Press release

Nokia Corporation Stock Exchange Release 19 April 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 19.04.2024 Espoo, Finland – On 19 April 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL430,8933.30CEUX--BATE--AQEU--TQEX--Total430,8933.30 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 4 April 2023 started on 20 March 2024 and ends by 18 December 2024 with a maximum aggregate purchase price of EUR 300 million. Total cost of

Landsbankinn hf.: Results of the 2024 AGM of Landsbankinn19.4.2024 20:48:08 CEST | Press release

The annual general meeting (AGM) of Landsbankinn, held on 19 April 2024, agreed to pay a dividend amounting to ISK 16,535 million to shareholders. The dividend is equivalent to 50% of 2023 profits. The dividend will be paid in two instalments, firstly on 24 April 2024 and secondly on 16 October 2024. As a result, total dividend paid by the Bank in 2013-2024 amounts to ISK 191.7 billion. At the AGM, held in Reykjastræti 6, Helga Björk Eiríksdóttir, Chairman of the Board of Directors, delivered the report from the Board for 2023. Lilja Björk Einarsdóttir, CEO, spoke of the Bank’s operation, strategy and activities in the past operating year. The annual financial statement for the past operating year was approved, as was the proposed Remuneration Policy and remuneration to Directors of the Board. The AGM elected the Auditor General (Ríkisendurskoðun) as auditor of Landsbankinn hf. for the 2024 operating year. The Auditor General, in accordance with an authorisation to outsource tasks, and

SKEL fjárfestingafélag hf.: Styrkás finalizes the purchase of Stólpi Gámar ehf. and affiliated companies.19.4.2024 19:20:57 CEST | Press release

Reference is made to the announcement dated 31 January 2024, regarding Styrkás hf., a company 69.64% owned by SKEL fjárfestingafélag hf., signing a purchase agreement to acquire 100% of the shares in six subsidiaries of Máttarstólpi ehf. The purchase agreement was subject to the approval of the Competition Authority. The transaction was finalized today with payment of purchase price and delivering of shares in the following companies: - Stólpi Gámar ehf., id. 460121-1590, Klettagörðum 5, 104 Reykjavík: - Stólpi Smiðja ehf., id. 460121-1750, Klettagörðum 5, 104 Reykjavík; - Klettskjól ehf., id. 460121-0510, Klettagörðum 5, 104 Reykjavík; - Stólpi ehf., 460121-0430, Klettagörðum 5, 104 Reykjavík; - Tjónaþjónustan ehf., id. 460121-1670, Klettagörðum 5, 104 Reykjavík; - Alkul ehf., id. 491020-0830, Haukdælabraut 48, 113 Reykjavík. collectively referred to as "the sold companies". These companies will continue to be operated on a consolidated basis. The Enterprise value of the sold companie

HiddenA line styled icon from Orion Icon Library.Eye